Nurx Launches First COVID-19 Home Testing & Online Consultation Service

Regulatory NOVARTIS: New analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment Apr 1, 2020

Industry News AMYRIS: Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant Mar 30, 2020

Innovation CONVERSA HEALTH: Top health systems use Conversa to handle coronavirus capacity crisis Mar 22, 2020

State Issues APHA: Issues Preparedness and Prevention Guidance During Coronavirus Pandemic Mar 6, 2020

Industry News ACELRX: Announces Agreement for an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Spine Surgery Mar 6, 2020

Regulatory APHA: Urges Regulators to Revise Their Review Process of Healthcare Vertical Mergers Feb 28, 2020

Federal Issues

SENTRY DATA SYSTEMS: launches pharmacy claims management solution to help reduce denials and improve claims processing Nov 5, 2019

• REGENERON PHARMACEUTICALS, INC.: U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
• AQUESTIVE THERAPEUTICS: Granted Temporary Restraining Order (TRO) Against Alvogen
• PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: PCMA Supports Legislation to Ensure Patients Pay Lowest Price for Prescription Drugs
• U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States

Industry News

AMYRIS: Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant Mar 30, 2020

• ACELRX: Announces Agreement for an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Spine Surgery
• AVION PHARMACEUTICALS: New gout prophylaxis product, GLOPERBA®, is the first and only liquid form of colchicine (1,2)
• PTCE: Pharmacy Times Continuing Education™ to Present Three Educational Symposia at the Hematology/Oncology Pharmacy Association 16th Annual Conference
• RXSENSE: Joins Health Plan Alliance Group Purchasing Organization

Innovation

CONVERSA HEALTH: Top health systems use Conversa to handle coronavirus capacity crisis Mar 22, 2020

• Nurx Launches First COVID-19 Home Testing & Online Consultation Service
• QUAVA PHARMA: QuVa Pharma® and Smiths Medical Increase Access to Pre-Filled CADD® Medication Cassette Reservoirs for Essential Compounded Sterile Products
• AMERICAN PHARMACISTS ASSOCIATION: APhA Alarmed by HHS/FDA Drug Importation Plans
• CONCERT PHARMACEUTICALS: Successfully Completes Open Label Trial of CTP-543 in Patients with Alopecia Areata

People

APRECIA: Kimberly Bone, PharmD, named Aprecia's Vice President of Medical & Clinical Affairs Aug 30, 2019

• VERTEX PHARMACEUTICALS INCORPORATED: Vertex Appoints Ludovic Fenaux as Senior Vice President, International Commercial Operations
• NFL legend Boomer Esiason gives a face and voice to thousands affected by cystic fibrosis
• ScriptSave WellRx wins conference product class award
• Rite Aid rolls out KidCents Safe Medication Disposal Program

Regulatory

NOVARTIS: New analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment Apr 1, 2020

• APHA: Urges Regulators to Revise Their Review Process of Healthcare Vertical Mergers
• Save on Prescriptions with ValpakRx
• CNS PHARMACEUTICALS: Completes Pilot Manufacturing Steps Pursuant to FDA Pre-IND Guidance
• LOOPBACK ANALYTICS: Loopback Analytics and UF Health Jacksonville Working Together on Specialty Pharmacy to Improve Patient Outcomes

State Issues

APHA: Issues Preparedness and Prevention Guidance During Coronavirus Pandemic Mar 6, 2020

• AMERICAN PHARMACISTS ASSOCIATION: Applauds Laws Prohibiting PBM 'Gag Clauses'
• ScriptSave WellRx wins conference product class award
• Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
• Merck and University of Oxford release positive results from REVEAL study of anacetrapib